DMYD B — Diamyd Medical AB Share News
0.000.00%
Last trade - 00:00- SEK141.62m
- -SEK6.19m
- SEK0.13m
Brief: Diamyd Medical Contracts Global CRO For Phase III Trial With Diabetes Vaccine Diamyd
Brief: Diamyd Medical: Fully Recruited Clinical Trial In Lada With Diamyd
Brief: Diamyd Medical Q2 Net Result Down At SEK 15.1 Mln
Brief: Diamyd Medical AB Intends To Carry Out A Directed Share Issue Of B-Shares
Brief: Diamyd Medical Makes An Investment In MainlyAI
Brief: Diamyd Medical Q1 Net Result Turns To Profit Of SEK 104.9 Mln
Brief: Diamyd Medical - Positive Safety Evaluation Of Remygen®
Brief: Diamyd Medical Says Immunological Analysis Of Phase IIB Trial With Diamyd Show Differences Between Genetically Defined Patient Groups
Brief: Diamyd Medical Enters Collaboration With Critical Path Institute
Brief: Diamyd Medical With Mainlyai And KTH Awarded Vinnova Funding For Ai Driven Sustainable Production
Brief: Diamyd Medical AB Says Annual General Meeting Of Diamyd Medical AB (Publ) Was Held On November 26, 2020.
Brief: Diamyd Medical To Fully Subscribe For Its Pro Rata Share In NextCell Pharma
Brief: Diamyd Medical To Get Additional USD 3.2 Million In Connection With Divestment Of Companion Medical
Brief: Diamyd Medical: Financial, Operational Update On Diabetes Vaccine
Brief: Diamyd Medical Q4 Net Loss Widens To SEK 13.5 Mln
Brief: Diamyd Medical Gets USD 13.9 Mln In Connection With Divestment
Brief: Diamyd Medical Phase IIb Topline Results Demonstrate A Significant Treatment Effect Of Diamyd
Brief: Diamyd Medical Provides Update On Diabetes Vaccine Diamyd
Brief: Clinical Trial With Remygen Expanded To Evaluate Prevention Of Hypoglycaemia